NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Blood Product Supply

CompletedN/A

Sponsor: Methodist Health System

Conditions: COVID-19

Interventions: Document delays and frequencies of inadequate blood products for emergent cases

Countries: United States

Data about the links between Coronavirus disease 2019(COVID-19) and the safety of blood products during the pandemic is inadequate. During the COVID-19 pandemic, high volumes of patients receiving blood products due to post-terminal surgical complications depleted stores for the entire hospital, resulting in surgeons unable to acquire emergent blood products. Data from this study can be used to develop a policy on how to handle blood shortage issues during this and future pandemics. Also, this data can be used to determine future policies on use of blood products from COVID-19-positive donors.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\>\_18 years of age Surgical patients treated at Methodist Dallas Medical Center(MDMC)

Exclusion Criteria:

\<18 years of age Prisoners Pregnant women

Locations (1)

Dallas, Texas, United States